Stock Analysis
Intuitive Surgical Inc.ISRG
P/E 48.03×· 5Y range 37.44–236.94×· bottom 7% of history
Sector: Healthcare · Industry: Medical Devices
AnalystsStrong Buy40 analystsP/E 48.0× sits at the 7th percentile of its 5.086926762491444-year history.
PMP Verdict
Strong business, attractive price
Strengths
- Profitability90
- Growth85
High-quality business at an attractive price.
Bull Case
- ✓Altman Z 38.5 — safe-zone balance sheet
- ✓ROE 17.6% — efficient capital deployment
- ✓Revenue CAGR 15.2% — durable top-line growth
- ✓P/E 48.0× at bottom 7% of 5-year history
What's happening with ISRG
Profile
Strong moat, profitability, growth, earnings quality and financial health; valuation lags behind.
How is each axis scored?
- Valuation45/100 · Weak
- P/E vs own history (7th pct)25/25
- FCF yield (2.2%)5/25
- P/S (13.5x)5/25
- EV/EBIT (n/a)10/25
- Growth85/100 · Strong
- Revenue CAGR (15.2%)20/25
- Net income CAGR (13.8%)20/25
- EPS CAGR 5Y (14.0%)20/25
- Fwd implied growth (38.9%)25/25
- Profitability90/100 · Strong
- ROIC (22.9%)20/25
- ROE (17.6%)20/25
- Net margin (28.4%)25/25
- Operating margin (31.3%)25/25
- Financial Health75/100 · Strong
- Altman Z (38.48)25/25
- Current ratio (4.87)25/25
- Interest coverage (no interest expense)25/25
- Net cash / debt (n/a)0/25
- Quality85/100 · Strong
- Piotroski F (6/9)15/25
- Beneish M (-2.31)20/25
- FCF conversion (103%)25/25
- Margin stability (σ 3.8%)25/25
- Moat100/100 · Strong
- ROIC >12% years (10/10 yrs)25/25
- Median gross margin (68.4%)25/25
- FCF-positive years (10/10 yrs)25/25
- Worst-year net margin (worst 21.1%)25/25
Risk Flags
- ⚠SBC 7.5% of revenue — real dilution cost
About Intuitive Surgical Inc.
Intuitive develops, produces, and markets a robotic system for assisting minimally invasive surgery. Show more
It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 11,000 da Vinci systems in hospitals worldwide, with more than 6,600 installations in the US and a growing number in emerging markets.
Headquarters: SUNNYVALE, CA · Employees: 17,021 · Website ↗
Price History
Weekly Candlestick Chart — up to 5Y
Key Metrics
Financial snapshot · Tap any metric for its definition and grade
TTM Snapshot
trailing twelve months · YoYValuation
45D+P/E (TTM)47.6xD
Grade D: ExpensivePrice / TTM EPS (own statements) — vs own 5Y history: 37.4x–236.9x · 7th pct
P/FCF46.2xD
Grade D: ExpensivePrice / Free Cash Flow per share (Finnhub). Inverse of FCF yield — negative when FCF is negative
FCF Yield2.2%C
Grade C: LowTTM (OCF − CapEx) / Market Cap — vs own 5Y history: 0.2%–2.7% · 94th pct
P/S (TTM)13.54xD
Grade D: ExpensivePrice / TTM Revenue (own statements) — vs own 5Y history: 10.6x–72.9x · 13th pct
EV/EBITDA40.5xD
Grade D: ExpensiveEnterprise value / EBITDA (Finnhub) — capital-structure neutral
EV/Sales13.2xD
Grade D: Very expensiveEnterprise Value / TTM Revenue (Finnhub) — capital-structure neutral sales multiple
Forward P/E34.3xC
Grade C: ExpensivePrice / next-year EPS estimate — shows whether the TTM multiple is rich or just front-loading growth
P/B Ratio8.38xD
Grade D: Very expensivePrice to Book Value. Neg. equity = heavy buybacks
PEG Ratio2.76C
Grade C: ExpensiveFinnhub PEG — their P/E basis ÷ expected EPS growth. Suppressed when their P/E diverges >2× from our TTM P/E (different basis)
Dividend Yield—
TTM dividend yield (Finnhub) — annual dividends / price. None = no dividend; very high yield can signal distress
Payout Ratio—
Dividends / Net Income (Finnhub) — share of earnings paid out; >90% or negative = unsustainable
Profitability
90A+ROIC22.9%A
Grade A: MoatNOPAT (EBIT less ~21% tax) / invested capital (equity + debt − cash). Flagship quality metric — durable >15% signals a moat
ROE17.6%C
Grade C: AverageReturn on Equity. Neg. equity = heavy buybacks
ROA15.5%A
Grade A: StrongReturn on Assets (Finnhub) — Net Income / Total Assets; how efficiently assets produce profit
Net Margin28.4%A
Grade A: HighNet Income / Revenue
Operating Margin31.3%A
Grade A: HighTTM EBIT / TTM Revenue
Gross Margin66.7%A
Grade A: PremiumGross Profit / Revenue
FCF Margin29.2%A
Grade A: HighFCF / Revenue
True FCF Margin21.7%A
Grade A: HighTTM (OCF − CapEx − SBC) / TTM Revenue — SBC treated as a real cost
Growth
85ARevenue CAGR15.2%A
Grade A: HighCompound annual revenue growth (up to 5Y depending on data availability)
Net Income CAGR13.8%C
Grade C: OkCompound annual net income growth (up to 5Y depending on data availability)
EPS CAGR (5Y)14.0%C
Grade C: OkCompound annual EPS growth over up to 5Y of per-share earnings (own statements). Null when either endpoint EPS ≤ 0
Implied EPS Growth38.9%A
Grade A: HighAnalyst forward EPS (normalized basis) vs our GAAP TTM EPS — different bases, so extreme values usually mark cyclically depressed TTM earnings, not real growth
Dilution (5Y)-3.1%A
Grade A: BuybacksShare count change over 5Y
SBC / Net Income26.3%D
Grade D: HighStock-based comp/Net income. >30% = dilution risk
SBC / Revenue7.5%C
Grade C: MedTTM stock-based comp / TTM Revenue
Financial Health
75B+Altman Z-Score38.48A
Grade A: SafeBankruptcy risk. >3 Safe, <1.8 Distress
Current Ratio4.87xA
Grade A: HighCurrent Assets/Liabilities
Quick Ratio3.65xA
Grade A: High(Current Assets − Inventory) / Current Liabilities (Finnhub) — stricter liquidity test, excludes inventory
Interest Coverage—
EBIT/Interest. >10 Strong
Debt Repayment—
Years to repay net debt via FCF
Net Debt/EBIT—
Leverage. <2x Low, >4x High
Debt/Equity0.00xA
Grade A: LowDebt / Equity: <1 Conservative, >2 Risky. Not meaningful with non-positive equity; shown as unavailable rather than low debt.
Cash / Debt—
Cash covers how much of total debt. >1 = could repay all debt from cash
Quality
85APiotroski F-Score6/9C
Grade C: AverageFinancial strength 0–9. >7 Strong
Beneish M-Score-2.31A
Grade A: SafeEarnings manipulation risk. < -2.22 Safe
FCF Conversion102.7%A
Grade A: StrongFCF / Net Income
Margin Stability3.8%A
Grade A: StableEBIT margin std deviation. Lower = stable
Capex / Revenue4.4%A
Grade A: Asset-lightTTM CapEx / TTM Revenue — high % = capital-hungry business
Asset Turnover0.55xC
Grade C: AverageRevenue / Total Assets (Finnhub) — how efficiently the asset base generates sales
Insider Transactions
SEC Form 4 · 8 recordsP/S codes are the directional signal; grants, option exercises and tax withholding carry none. Form 4 doesn't flag 10b5-1 plans — scheduled sales may appear within open-market sells.
| Trade date | Insider | Transaction | Shares | Filed |
|---|---|---|---|---|
LOEB GARY Filed | LOEB GARY | Option exercise | -2612 | |
LOEB GARY Filed | LOEB GARY | Tax withholding | -1296 | |
LOEB GARY Filed | LOEB GARY | Option exercise | +2.6K | |
WADORS PATRICIA L Filed | WADORS PATRICIA L | Option exercise | -2140 | |
WADORS PATRICIA L Filed | WADORS PATRICIA L | Tax withholding | -1062 |
Show 3 more filingsShow fewer filings
| Trade date | Insider | Transaction | Shares | Filed |
|---|---|---|---|---|
WADORS PATRICIA L Filed | WADORS PATRICIA L | Option exercise | +2.1K | |
Widman Fredrik Filed | Widman Fredrik | Option exercise | -543 | |
Widman Fredrik Filed | Widman Fredrik | Option exercise | -546 |
Option exercise (M) rows report a derivative leg, not an open-market sale — a paired negative entry is the option position being consumed.
More metrics — Moat, Per Share, Balance Sheet, MarketHide additional metrics
Moat
100A+ROIC >12% Years10/10 yrsA
Grade A: DurableShare of completed fiscal years with ROIC > 12% — measures multi-year capital-return durability
Gross Margin (Med.)68.4%A
Grade A: DurableMedian annual gross margin across available fiscal years — pricing-power durability
FCF-Positive Years10/10 yrsA
Grade A: DurableShare of completed fiscal years with positive free cash flow
Net Margin Floor21.1%A
Grade A: DurableWeakest annual net margin across completed fiscal years — recession/downcycle resilience
Per Share
EPS (TTM)$8.88
Own TTM net income / shares — same earnings basis as P/E
Cash / Share$15.03
Cash & short-term investments per share (Finnhub)
Book Value / Share$51.34
Shareholders' equity per share (Finnhub). Negative = accumulated losses / heavy buybacks
Balance Sheet
Total Debt—
Total debt obligations (short + long term)
Cash & Equiv.$5.93B
Cash and short-term investments
Net Debt—
Total Debt minus Cash. Negative = Net Cash position
Total Equity$17.82B
Shareholders' equity (book value)
Asset / Liability8.13xA
Grade A: SolidTotal Assets / Total Liabilities
Market
Market Cap$149.44B
Current Market Capitalization
Beta1.46C
Grade C: VolatilePrice sensitivity vs the market (Finnhub) — 1.0 moves with market, >1.2 amplifies swings
How grades work: each metric is graded A–D against fixed thresholds (tap a row for the meaning). Card grades map the pillar score to A+–E — a card grade is that pillar's own score, not an average of the rows shown.
Financials as of Jun 2026 · Ratio snapshot Oct 17, 2026
Key Insights: Intuitive Surgical Inc. (ISRG)
Piotroski F-Score of 6/9 indicates mixed fundamentals for Intuitive Surgical Inc.. Altman Z-Score of 38.48 sits comfortably in the safe zone (≥ 2.99), indicating low bankruptcy risk. Beneish M-Score of -2.31 suggests a low likelihood of earnings manipulation.
- Revenue has compounded at roughly 15% annually, with net income growing about 14% per year — a strong growth profile.
- Intuitive Surgical Inc. converts about 29% of revenue into free cash flow — strong cash generation.
See how ISRG ranks on the Capex Tracker — top 50 capital spenders compared.
No significant market moves for ISRG in the last 30 days.
See ISRG move history →Frequently Asked Questions about ISRG
What is the current Intuitive Surgical Inc. (ISRG) stock price?
ISRG is trading at $426.70 at the last market close, down 0.27% on the session. PreMarketPrice tracks ISRG pre-market, intraday and after-hours prices.
Is ISRG stock a buy right now?
PreMarketPrice's quantitative model rates Intuitive Surgical Inc.'s financial health at 75/100. This is a data-driven snapshot of fundamentals, not investment advice.
Is ISRG stock overvalued?
Intuitive Surgical Inc. trades at a trailing P/E of 47.6 and our valuation score rates it 45/100 (higher = cheaper vs. its own history). See the Valuation History and Key Metrics sections for forward P/E, EV/EBITDA and PEG context.
When does Intuitive Surgical Inc. report earnings?
No confirmed earnings date is currently scheduled for ISRG. The Earnings section lists recent reports and updates as dates are announced.
What sector does Intuitive Surgical Inc. operate in?
Intuitive Surgical Inc. operates in the Healthcare sector, within the Medical Devices industry. The Related Stocks section lists sector peers for comparison.
What does Intuitive Surgical Inc. do?
Intuitive develops, produces, and markets a robotic system for assisting minimally invasive surgery.
About Intuitive Surgical Inc. (ISRG) Stock
Intuitive Surgical Inc. (ISRG) is a US-listed stock operating in the Healthcare sector, specifically the Medical Devices industry. As of the latest update, Intuitive Surgical Inc. is trading at $426.70, down 0.27% on the day with a market capitalization of $149.4 billion. The financial health score for ISRG is 75/100, which indicates excellent financial strength based on profitability, leverage, liquidity, and growth metrics. This page provides real-time pre-market pricing, earnings calendar, financial health analysis, and valuation metrics for ISRG stock.
ISRG Stock Analysis & Key Metrics
On PreMarketPrice, you can track Intuitive Surgical Inc. (ISRG) across multiple dimensions:
- Pre-market price & movement: Real-time ISRG stock price with percentage change, updated continuously during pre-market and regular trading hours.
- Valuation & P/E history: Historical P/E, P/S, and P/B ratios for ISRG with trend analysis and normalized valuation multiples.
- Financial statements: Revenue, net income, assets, liabilities, and equity for Intuitive Surgical Inc. across multiple reporting periods.
- Financial health score: A composite score of 75/100 based on Altman Z-Score, Piotroski F-Score, profitability, and leverage metrics for ISRG.
- Sector peers: Compare ISRG against 6 other healthcare stocks on key financial metrics.
Is ISRG a Good Stock to Buy?
This page provides data-driven analysis to help you evaluate Intuitive Surgical Inc. (ISRG) as an investment. The financial health score of 75/100 suggests excellent financial fundamentals. Valuation metrics show whether the stock is trading above or below its historical average.However, this is not financial advice — always do your own research before investing.
Data on this page is sourced from real-time market feeds, Polygon.io, and Finnhub.Intuitive Surgical Inc. (ISRG) trades on NYSE/NASDAQ. Pre-market trading occurs 4:00 AM – 9:30 AM ET. Regular market hours are 9:30 AM – 4:00 PM ET.